Planning for Success

Since its inception in 2002, the use of transcatheter aortic valve replacement (TAVR) has rapidly increased over the last 17  years.1,2 Many of the challenges encountered in the early phases of TAVR adoption have been overcome with technological improvements in both the transcatheter valves and delivery systems.3,4 Nonetheless, as TAVR indications broaden to include lower-risk populations,5,6 detailed pre-procedural plan ning is crucial to maintain the safety and efficacy of this therapy. The 2017 American College of Cardiology (ACC) Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement suggested a decision pathway for clinicians caring for patients with aortic stenosis (AS).
Source: Cardiology Clinics - Category: Cardiology Authors: Source Type: research